Association of Metabolic Syndrome with Albuminuria in Diabetes Mellitus Type 2
Background : Metabolic syndrome is a risk factor for cardiovascular disease as well as the occurrence of chronic kidney disease. According to the IDF, the metabolic syndrome is diagnosed when central obesity obtained with 2 or more metabolic abnormalities that include impaired glucose metabolism, increased blood pressure, hypertriglyceridemia, and low HDL-C. Several previous studies reported an significant association found between the metabolic syndrome with albuminuria. In Indonesia, the association of metabolic syndrome with albuminuria in type 2 diabetes have not been.reported.
Objectives : To investigate the association of metabolic syndrome with albuminuria in type 2 diabetes patients.
Methods : This is an analytic observational study, cross-sectional design in type 2 diabetes mellitus patients and we studied 131 subjects. Criteria metabolic syndrome according to IDF consensus and albuminuria assessed using the ACR method and the classification of albuminuria was based on consensus of Perkeni 2006. As for Statistical analysis using spearman correlation and Mann-whitney test. Significance level used was 0.05.
Results : Of the 131 type 2 diabetes patients with metabolic syndrome were found normoalbuminuria proportion 65.4%, microalbuminuria 27.1% and macroalbuminuria 7.5%. Obtained a significant association between systolic blood pressure with albuminuria, p = 0.000, r = 0.325. Fasting blood sugar with albuminuria, p = 0.01, r = 0.223. But not found significant association between diastolic blood pressure with albuminuria, p = 0.153, r = 0.125, waist circumference with albuminuria, p = 0.311, r = 0.089, low HDL with albuminuria p = 0.771, r = -0.025. Hypertriglyceridemia with albuminuria, p = 0.727 and r=0,031
Conclusion : The results of this study indicate a strong association between the components of metabolic syndrome, systolic blood pressure with albuminuria, and fasting blood sugar with albuminuria. Whereas diastolic blood pressure, waist circumference, low HDL, and hypertriglyceridemia were not found significant associations.
Adam JMF (2006). Dislipidemi pada sindroma metabolik. Obesitas dan sindroma metabolik. Bandung. Perkeni, p 101-117
AHA (2008). Metabolik syndrome. New York. American Heart Association, pp 3-14
Brownlee M (2005). The pathobiology of diabetic complications. Diabetes Journal 54, 1615
Chiowanich P, Kanjanabuch T, Oravivattanaku S, et al (2009). Prevalence and risk factors of microalbuminuria in patient with diabetic mellitus at northern part referral hospital in thailand. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 3, 152
Cirillo M, Laurenzi M, Mancini M, et al (2006). Low muscular mass and overestimation of microalbuminuria by urinary albumin/creatinine ratio. Hypertension Journal 47, 56-61
Earle K.A, Harry D, Zitouni K (2008). Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes. Diabetes Research and Clinical Practice 79, 68
Hana F, Zia A K, Harkiran K et al (2006). Vascular endothelial dysfunction in diabetic cardionyopathy: pathogenesis and potential treatment target. Pharmacology & Therapeutic 111, 384-399
Hao Z, Konita T, Takasaki S et al (2006). The association between microabuminuria and metabolic sundrome in the general population in Japan: The Takahata study. The Japanese Society of Internal Medicine. Available from http://www.naika.or.jp/imindex.html. Accessed August 12, 2010
IDF (2006). The IDF concensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org/. Accessed February, 22 2010
Jafar TH, Chaturvedi N, Hatcher J et al (2007). Use of albumin creatinin ratio and urine albumin concentration as a screening test for albuminuria in a Indo-Asian population. Nephrol Dial Transplant 10, 1-7
Jorgensen ME, Bjerregaeed P, Gyntelberg F et al (2004). Prevalence of the metabolic syndrome among the inuit in the Greenland. Diabetes Medicine 21, 1237-1242
Li H, Telemaque S,Miller RE et al (2005). High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle sell via upregulation of Bcl-2 and Bcl-xl. Diabetes 54, 540-545
Michel ES, Frederique T, Jacques B (2006). Metabolic syndrome and age-related progression of aortic stiffness. Journal of the American College of Cardiology 47, 72-75
Palaniappan L, Carnethon M, Fortmann SP (2003). Association between micro albuminuria and the metabolic syndrome: NHANES III. Am J Hypertens. 16, 952-958
PERKENI (2006). Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di indonesia. Jakarta, 3-30
Pranoto A, Kholili U, Tjokroprawiro A, et al (2005). Metabolic syndrome as observed in Surabaya. Naskah Lengkap Surabaya Metabolic Syndrome 1, 245-247
Tjokroprawiro, A (2008). The metabolik syndrome: capita selecta-2008 (from basic to possible clinical application). Naskah Lengkap Metabolik Cardiovascular Disease Surabaya Update-2 (MECARSU-2) Surabaya Metabolik Syndrome Update-4 (SUMETSU-4). Surabaya. Universitas Airlangga, p 79-88
Tseng, CH , (2009). Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan. Clinical Biochemistry 42, 1019
Wang (2006). Albuminuria as a marker of the risk ofdeveloping type 2 diabetes in non-diabeticaboriginal Australians. International journal of epidemiology 35, 1331–1335
Wanner C, Quaschning T (2001). Dyslipidemia and renal disease: pathogenesis and clinical consequences. Current Opinion in Nephrology and Hypertension 10, 195-201
William TC, Christopher PC (2007). Atlas of cardiometabolic risk : Classification and evolution of increased cardiometabolic risk state. Informa Heathcare, 13-25
Zimmet P, Albert G, Kaufman F et al (2007). The metabolic syndrome in children and adolescents: the IDF concensus. Diabetes Voice 25, 29-32
Zoppini, G., Targher, G., Chonchol, M et al (2009). Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes. Nutrition, Metabolism & Cardiovascular Diseases 19, 580
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).